论文部分内容阅读
目的研究分析舒血宁加脑复康治疗脑梗死的临床疗效。方法选取我院2011～2012一年之内接收的脑梗死患者120例,将其进行随机分组,分为治疗组与对照组2组,每组60例。2组患者均根据患者情况给予常规的治疗,包括降低颅内压、控制血脂、血糖、降血压、抗凝、保护脑细胞等,对于治疗组的患者,在采取以上常规方法的基础上,另外加用舒血宁和脑复康的治疗方式,对照组在以上常规治疗基础上加用复方丹参注射液,观察2组患者治疗的总有效率和欧洲脑卒中量表评分的变化情况。结果临床治疗效果表明,治疗组患者的总体有效率达到96.7%,相比对照组患者的总体有效率66.7%,具有明显的优势,2组患者的差异具有统计学意义P<0.05;治疗的患者在接受治疗之后,其欧洲脑卒中量表的评分结果明显的比对照组高,差异有统计学意义P<0.05。结论舒血宁加脑复康对于改善脑梗死患者神经功能缺损症状有很好的疗效,值得在临床上推广应用。
Objective To study the clinical effect of Shuxuening plus Naofukang on cerebral infarction. Methods A total of 120 patients with cerebral infarction received within one year from 2011 to 2012 in our hospital were randomly divided into two groups: treatment group and control group, 60 cases in each group. The two groups of patients were given conventional treatment according to the patient’s condition, including reducing intracranial pressure, controlling blood lipids, blood sugar, lowering blood pressure, anticoagulation, protecting brain cells, etc. For the patients in the treatment group, on the basis of the above conventional methods, Plus Shuxuening and norafukate treatment, the control group in the above conventional treatment plus compound Salvia injection to observe the total effective rate of treatment of two groups and changes in the European Stroke Scale score. Results The results of clinical treatment showed that the overall effective rate of the treatment group reached 96.7%, compared with 66.7% of the total effective rate of the control group patients, with obvious advantages. The difference between the two groups was statistically significant (P <0.05). The treated patients After receiving treatment, the European Stroke Scale scores significantly higher than the control group, the difference was statistically significant (P <0.05). Conclusion Shuxuening plus Naofukang has a good curative effect on improving neurological deficit symptoms in patients with cerebral infarction, which is worth popularizing in clinic.